Furthermore, overexpression of YTHDF1/2, YTHDC1, RBM15, and METTL3 is significantly correlated with the clinical stage of hepatocellular carcinoma, while downregulation of ZC3H13 and METTL14 is associated with poor prognosis [270]. This evidence concerns the gene METTL14 and hepatocellular carcinoma.